Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 112

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 6
Chunk 112
---
 meeting of shareholders. Under our Constitution, a director, other than the Managing Director, must not hold office for
more than three years or beyond the third annual general meeting following his appointment (whichever is the longer period) without submitting
himself for re-election. Our Board of Directors has the power to appoint any person to be a director, either to fill a vacancy or as an
additional director (provided that the total number of directors does not exceed the maximum allowed by law), and any director so appointed
may hold office only until the next annual general meeting (“ AGM”) when he or she shall be eligible for election.

The appointment and expiration dates of each director
in office on June 30, 2025, is as follows:

  Name                   Position                     Year first      Current term  
                                                       appointed      expires       
  Riccardo Canevari      Managing Director & CEO            2021      — (1)         
 ────────────────────────────────────────────────────────────────────────────────────
  Paul Hopper            Executive Chairman                 2021      2025 (2)      
  Ian Turner             Non-Executive Director             2021      2027 (2)      
  Hester Larkin          Non-Executive Director             2022      2025 (2)      
  Leila Alland           Non-Executive Director             2022      2025 (2)      
  Phillip Hains          Executive Director                 2024      2027 (2)      
  Noel Donnelly          Non-Executive Director             2024      2027 (2)      

  (1)      In accordance with our Constitution and Australian market practice, the Managing Director’s appointment is not subject to expiration.                                   
  (2)      Term expires on the date of the AGM for that year. Our constitution provides that at least one director has to be reappointed after three years from their appointment  

Corporate Governance

ASX Corporate Governance Principles

In Australia, there are no
defined corporate governance structures and practices that must be observed by a company listed on the ASX, except that entities of a
certain size are required to have audit and remuneration committees and, in some instances, trading policies for key management personnel.
Instead, the ASX Corporate Governance Council has published the Corporate Governance Principles and Recommendations, which contains what
are called the Recommendations which articulate eight core principles which are intended to provide a reference point for companies about
their corporate governance structures and practices. Under AS